Ardelyx, Inc (ARDX) PT Raised to $16 at Wedbush; Tenapanor Approval in IBS-C 'Almost Certain'
Tweet Send to a Friend
Wedbush analyst David Nierengarten raised his price target on Ardelyx, Inc (NASDAQ: ARDX) to $16.00 (from $14.00) while maintaininan a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
